CLINICAL_TRIALS
trial_result
· 2016-06-21
Clinical Trial Update: Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis [Phase 3]
Summary
Phase 3 trial update on adalimumab for inactive uveitis reports efficacy and safety results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Uveitis | Phase 3 | Status: COMPLETED | Results posted: 2016-06-21